Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma.
Yaseen B, Lopez H, Taki Z, Zafar S, Rosario H, Abdi BA, Vigneswaran S, Xing F, Arumalla N, Black S, Ahmad S, Kumar K, Gul R, Scolamiero L, Morris S, Bowman A, Stainer A, Rice A, Stock C, Renzoni E, Denton CP, Venturini C, Brown M, O'Reilly S, Stratton R.
Yaseen B, et al.
Rheumatology (Oxford). 2020 Sep 1;59(9):2625-2636. doi: 10.1093/rheumatology/keaa195.
Rheumatology (Oxford). 2020.
PMID: 32365362